May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Vasoproliferative Tumours of the Retina: Management and Outcomes of 19 Patients
Author Affiliations & Notes
  • J. Garcia-Arumi
    Ophthalmology, Hosp Vall d Hebron, Barcelona, Spain
  • A. Fonollosa
    Ophthalmology, Hosp Vall d Hebron, Barcelona, Spain
  • M. A. Zapata
    Ophthalmology, Hosp Vall d Hebron, Barcelona, Spain
  • A. Boixadera
    Ophthalmology, Hosp Vall d Hebron, Barcelona, Spain
  • V. Martinez-Castillo
    Ophthalmology, Hosp Vall d Hebron, Barcelona, Spain
  • C. Macia
    Ophthalmology, Hosp Vall d Hebron, Barcelona, Spain
  • E. Santos
    Ophthalmology, Hosp Vall d Hebron, Barcelona, Spain
  • Footnotes
    Commercial Relationships  J. Garcia-Arumi, None; A. Fonollosa, None; M.A. Zapata, None; A. Boixadera, None; V. Martinez-Castillo, None; C. Macia, None; E. Santos, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 5949. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      J. Garcia-Arumi, A. Fonollosa, M. A. Zapata, A. Boixadera, V. Martinez-Castillo, C. Macia, E. Santos; Vasoproliferative Tumours of the Retina: Management and Outcomes of 19 Patients. Invest. Ophthalmol. Vis. Sci. 2008;49(13):5949.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To describe the clinical features, complications, management and outcomes of 19 consecutive patients with vasoproliferative tumour of the retina (VTR).

Methods: : Retrospective analysis of clinical records.

Results: : 19 cases of VTR in 19 patients were examined with a follow up period between 5 months and 132 months. The mean age was 35.6 years. 11 were male and 8 female. There was 1 secondary case associated to Retinitis Pigmentosa.Ophthalmological changes associated with VTR were serous retinal detachment and hard exudates (n=11 ), macular edema (n= 7 ), vitreoretinal proliferation (n=5), epiretinal membrane (n=2 ), subretinal, vitreous or subhyaloid haemorrhage (n= 5). Treatment of tumour consisted of photocoagulation (n=13), cryotherapy (n= 7 ) and observation (n=1). Treatment of complications consisted of vitrectomy (n=11), scleral buckle (n=3). 8 cases received also intravitreal triamcinolone and or bevacizumab to treat exudation. 7 tumours needed retreatment. 3 cases needed retreatment due to persistent cystoid macular edema. Regression of the tumour could be observed in all treated cases. Visual acuity at last follow-up improved or remained unchanged in 10 cases.

Keywords: tumors • vitreoretinal surgery • retinal glia 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×